project id: TCGA-SKCM; case submitter id: TCGA-EB-A44R; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.64; rna integrity number: 9.0; age at index: 52; days to birth: -19298; days to death: 315; ethnicity: not hispanic or latino; gender: male; race: asian; vital status: Dead; year of birth: 1959; age at diagnosis: 19298; ajcc pathologic m: M0; ajcc pathologic n: N2b; ajcc pathologic stage: Stage IIIB; ajcc pathologic t: TX; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 309.0; icd 10 code: C77.4; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lymph nodes of inguinal region or leg; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 372; days to sample procurement: 0; initial weight: 940.0; portion submitter id: TCGA-EB-A44R-06A-41; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 85.0;